CME Program Q&A Panel Discussion

Dr. Bradstreet obtained his medical degree from the University of South Florida and his residency training at Wilford Hall USAF Medical Center. He is extensively published on the subjects of immunology, toxicology and molecular biology. Currently he is enhancing techniques for stem cell yield from adipose tissue. This work continues and enhances his efforts at immunotherapy, heavy metal detoxfication and restoration of a healthy gut ecosystem.

Dr. Richard Deth is Professor of Pharmacology in the Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University. His recent research has focused on the roles of oxidative stress and impaired methylation in autism, ADHD and other neurological, neuropsychiatric and neurodegenerative disorders.

Dr. Krigsman is a pediatrician and board certified pediatric gastroenterologist who has evaluated and treated over 1400 children suffering from autism and a variety of gastrointestinal problems. He maintains offices in both New York City and Austin, Texas, is actively involved in clinical research, and has presented his findings in peer reviewed journals, scientific meetings, and at a congressional hearing dealing with autism and its possible causes.

Kyle Van Dyke recieved his MD from the University of Chicago and completed his redsidency in Family Medicine at the University of Virginia. He is board certified in Family Medicine. He became involved in autism after the diagnosis of his son 7 years ago. His interests include clinical interventions, mitochondria, and hyperbaric therapy.